Literature DB >> 9378731

The effect of recombinant human bone morphogenetic protein-2 (rhBMP-2) on the healing of full-thickness defects of articular cartilage.

R S Sellers1, D Peluso, E A Morris.   

Abstract

Articular cartilage has a limited capacity for repair. We investigated the effect of rhBMP-2 (recombinant human bone morphogenetic protein-2) on the healing of full-thickness osteochondral defects in adult New Zealand White rabbits. A single defect, three millimeters wide by three millimeters deep, was created in the trochlear groove of the right femur in eighty-nine rabbits. The defect was either left empty, filled with a plain collagen sponge, or filled with a collagen sponge impregnated with five micrograms of rhBMP-2. The animals were killed at four, eight, or twenty-four weeks, and the repair tissue was examined histologically and evaluated with use of a grading scale. The defects also were examined immunohistochemically for the presence of type-II collagen at four and eight weeks. The rate of bone repair was evaluated with fluorescent labeling of bone at two and four weeks and with use of fluorescence microscopy at eight weeks. Treatment with rhBMP-2 greatly accelerated the formation of new subchondral bone and improved the histological appearance of the overlying articular surface. At twenty-four weeks, the thickness of the repair cartilage was 70 per cent that of the normal adjacent cartilage and a new tidemark usually had formed between the repair cartilage and the underlying subchondral bone. The average total scores on the histological grading scale were significantly better (p < 0.01) for the defects treated with rhBMP-2 than for the untreated defects (those left empty or filled with a plain collagen sponge) at all time-points. Immunostaining with an antibody against type-II collagen showed the diffuse presence of this cartilage-specific collagen throughout the repair cartilage in the treated defects. The untreated defects demonstrated minimum staining with this antibody.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9378731     DOI: 10.2106/00004623-199710000-00002

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  46 in total

Review 1.  Stem cells for repair of cartilage and bone: the next challenge in osteoarthritis and rheumatoid arthritis.

Authors:  C Jorgensen; D Noel; F Apparailly; J Sany
Journal:  Ann Rheum Dis       Date:  2001-04       Impact factor: 19.103

Review 2.  Could inflammatory arthritis be triggered by progenitor cells in the joints?

Authors:  C Jorgensen; D Noel; G Gross
Journal:  Ann Rheum Dis       Date:  2002-01       Impact factor: 19.103

3.  A novel method to examine the phenotype of chondrocytes.

Authors:  R Kuijer; D A Surtel; A J Van Der Linden; S K Bulstra; R C Passier
Journal:  J Mater Sci Mater Med       Date:  1998-12       Impact factor: 3.896

Review 4.  Pharmacologic therapy for osteoarthritis--the era of disease modification.

Authors:  David J Hunter
Journal:  Nat Rev Rheumatol       Date:  2010-11-16       Impact factor: 20.543

Review 5.  Cell-laden hydrogels for osteochondral and cartilage tissue engineering.

Authors:  Jingzhou Yang; Yu Shrike Zhang; Kan Yue; Ali Khademhosseini
Journal:  Acta Biomater       Date:  2017-01-11       Impact factor: 8.947

6.  B2A peptide induces chondrogenic differentiation in vitro and enhances cartilage repair in rats.

Authors:  Xinhua Lin; Shobana Shanmugasundaram; Yi Liu; Alexandrine Derrien; Maria Nurminskaya; Paul O Zamora
Journal:  J Orthop Res       Date:  2012-01-23       Impact factor: 3.494

Review 7.  [Bone morphogenetic proteins in the skeletal system].

Authors:  C P Bramlage; T Häupl; C Kaps; P Bramlage; G-A Müller; F Strutz
Journal:  Z Rheumatol       Date:  2005-09       Impact factor: 1.372

8.  Regulation of articular chondrocyte catabolic genes by growth factor interaction.

Authors:  Shuiliang Shi; Scott Mercer; George J Eckert; Stephen B Trippel
Journal:  J Cell Biochem       Date:  2019-02-27       Impact factor: 4.429

9.  Tracheal cartilage growth promotion by intra-tracheal administration of basic FGF.

Authors:  Makoto Komura; Hiroko Komura; Tetsuya Ishimaru; Kenichiro Konishi; Hiroaki Komuro; Kazuto Hoshi; Tsuyoshi Takato
Journal:  Pediatr Surg Int       Date:  2019-09-25       Impact factor: 1.827

10.  Cartilage constructs engineered from chondrocytes overexpressing IGF-I improve the repair of osteochondral defects in a rabbit model.

Authors:  H Madry; G Kaul; D Zurakowski; G Vunjak-Novakovic; M Cucchiarini
Journal:  Eur Cell Mater       Date:  2013-04-16       Impact factor: 3.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.